Molecular Engineering of Erythrotropic Bacteria for Treatment and Prevention of Human Malaria

Joseph DeRisi of the University of California at San Francisco proposes to engineer naturally occurring erythrotropic bacteria to target malaria infected red blood cells to serve as a potential prophylactic and treatment for malaria in humans.